How is the Tempest Therapeutics Inc today?

The Tempest Therapeutics Inc today is trading in the down by -3.15% at 6.46.

How has Tempest Therapeutics Inc performed historically?

The Tempest Therapeutics Inc is currently trading down -3.15% on an intraday basis in the past week the index fell -11.99%. The index has been up 609.89% in the past quarter and rose 73.19% in the past year. You can view this in the overview section.

What is Tempest Therapeutics Inc Annual Net Profit?

Tempest Therapeutics Inc Annual Net Profit fell 41.88% in the last year to $41.84 M. Its sector's average net profit growth for the last fiscal year was -32.49%.

What is Tempest Therapeutics Inc Price to Earning Ratio?

Tempest Therapeutics Inc Price to Earning Ratio is -0.56, which is negative.

What is Tempest Therapeutics Inc Stock Price?

Tempest Therapeutics Inc Stock Price rose 73.19% and outperformed its sector by 68.63% in the past year.

What is Tempest Therapeutics Inc Quarterly Net profit?

Tempest Therapeutics Inc Quarterly Net profit fell 84.47% YoY to $13.81 M. Its sector's average net profit growth YoY for the quarter was -29.04%.

What is Tempest Therapeutics Inc Debt to Equity Ratio?

Tempest Therapeutics Inc Debt to Equity Ratio of 0.8 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Tempest Therapeutics Inc Return on Equity(ROE)?

Tempest Therapeutics Inc Return on Equity(ROE) for the last financial year was -182.35%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Tempest Therapeutics Inc Mutual Fund Holding?

Tempest Therapeutics Inc Mutual Fund Holding increased by 0.26% in the last quarter to 3.35.

What is Tempest Therapeutics Inc Interest Coverage Ratio?

Tempest Therapeutics Inc Interest Coverage Ratio is -30.8, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Tempest Therapeutics Inc Institutional Holding?

Tempest Therapeutics Inc Institutional Holding decreased by 0% in the last quarter to 14.8.

Tempest Therapeutics Inc XNAS: TPST

Tempest Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Tempest Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Tempest Therapeutics Inc
Rating: 2.21925
Author: Trendlyne DVM scores

about

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic pr...

6.46 -0.21 (-3.15%)

1475.61% Gain from 52W Low

20,642 XNAS Volume

XNAS 07 May, 2025 11:17 AM (EDT)

Board Meeting

The next board meeting for Tempest Therapeutics Inc is on 09 May 2025 for the purpose of Tempest Therapeutics Inc First Quarter Earnings Results for 2025 See details

Not Eligible

Expensive Valuation

10.0 / 100

Technically Bullish

78.8 / 100

No estimates available

Tempest Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Tempest Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic pr...

1475.61% Gain from 52W Low

SWOT Analysis

Tempest Therapeutics Inc Live Price Chart

Tempest Therapeutics Inc FAQ

How is Tempest Therapeutics Inc today?

Tempest Therapeutics Inc today is trading in the red, and is down by -3.15% at 6.46.

How has Tempest Therapeutics Inc performed historically?

Tempest Therapeutics Inc is currently trading down -3.15% on an intraday basis. In the past week the stock fell -11.99%. stock has been up 609.89% in the past quarter and rose 73.19% in the past year. You can view this in the overview section.